Augmenix, Inc.

Augmenix, Inc.

Augmenix, Inc.

Overview
Date Founded

2008

Headquarters

201 Burlington Road,Bedford, MA 01730

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services

Company Description

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

Contact Data
Trying to get in touch with decision makers at Augmenix, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Executives & Employees

Chief Executive Officer

Chief Technology Officer & Director

Vice President, Regulatory & Quality

Vice President, Sales Training & Strategic Accounts

Vice President, Operations

Chief Operating Officer

Director

Project Manager

Offc Manager

Quality Control Manager

Board of Directors

Chairman & Chief Executive Officer at Instylla, Inc.

Managing Director at Ascension Ventures LLC

Co-Founder at Incept LLC

Chief Executive Officer at Augmenix, Inc.

Chief Technology Officer & Director at Augmenix, Inc.

Chief Executive Officer & Director at Lantos Technologies, Inc.

General Partner at Excelestar Ventures LLC

Director at Augmenix, Inc.

Paths to Augmenix, Inc.
Potential Connections via
Relationship Science
You
Augmenix, Inc.
Recent Transactions
Details Hidden

Boston Scientific Corporation purchases Augmenix, Inc. from Ascension Ventures LLC, Versant Venture Management LLC, Pinnacle Ventures LLC, Catalyst Health Ventures, Falcon Partners LLC, Excelestar Ventures LLC

Details Hidden

Augmenix, Inc. raised money in a private placement transaction

Details Hidden

Augmenix, Inc. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onBoston Scientific Corporation purchases Augmenix, Inc. from Ascension Ventures LLC, Versant Venture Management LLC, Pinnacle Ventures LLC, Catalyst Health Ventures, Falcon Partners LLC, Excelestar Ventures LLC

Investment Advisor

Advised onBoston Scientific Corporation purchases Augmenix, Inc. from Ascension Ventures LLC, Versant Venture Management LLC, Pinnacle Ventures LLC, Catalyst Health Ventures, Falcon Partners LLC, Excelestar Ventures LLC

Investors
Details Hidden

Catalyst Health Ventures focuses on early-stage investments in healthcare start-up companies. The firm seeks to invest in companies with technology-based healthcare solutions, rather than pure science. They tend to invest in medical devices and technology, life science instrumentation, and diagnostics. Within these market sectors, Catalyst Health Ventures looks for companies with strong management teams, credible execution plans and visions, sensible business models, large market potential and multiple exit options within 3 to 7 years. The firm concentrates on opportunities in greater Boston and the northeastern US.While Catalyst Health Ventures typically makes initial investments in a start-up at the early stage, they reserve capital for significant support and participation later on. Initial investments typically range from $1 million to $3 million, but the firm may invest more or less than, as appropriate. The firm generally expects to invest a total of $7 million to $12 million over the life of a portfolio company as it makes progress toward a successful exit.

Details Hidden

Pinnacle Ventures provides debt and equity financing to early-stage companies in the information technology, clean technology and healthcare sectors. The firm's venture debt products include: growth capital loans, equipment loans, subordinated debt, accounts receivables facilities, mezzanine notes, convertible debt, M&A financing and special situation facilities. For all of their venture debt products, initial investments range from $500,000 to $25 million. Pinnacle Ventures also makes equity investments in early-stage companies. The firm makes lead and minority investments, as well as seed investments. Pinnacle Ventures is able to lead rounds with investments up to $15 million. In these situations, the firm either takes a board seat or board observer rights. The firm also makes smaller minority investments in the range of $1 million to $5 million.

Details Hidden

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Augmenix, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Augmenix, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Augmenix, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/augmenix-inc-188905
  • https://relationshipscience.com/organization/augmenix-inc-188905